Literature DB >> 34731265

The Structures and Functions of VZV Glycoproteins.

Stefan L Oliver1.   

Abstract

The virions of all enveloped viruses, including those of the Herpesviridae, must bind to the cell surface then undergo a process of membrane fusion between the cell plasma membrane and the virus particle envelope. As for all herpesviruses, glycoproteins in the virion envelope are the modus operandi of these events.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Year:  2021        PMID： 34731265      PMCID： PMC9065213          DOI： 10.1007/82_2021_243

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.737


  139 in total

1.  Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Authors:  J C Whitbeck; C Peng; H Lou; R Xu; S H Willis; M Ponce de Leon; T Peng; A V Nicola; R I Montgomery; M S Warner; A M Soulika; L A Spruce; W T Moore; J D Lambris; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Sialic Acids on Varicella-Zoster Virus Glycoprotein B Are Required for Cell-Cell Fusion.

Authors:  Tadahiro Suenaga; Maki Matsumoto; Fuminori Arisawa; Masako Kohyama; Kouyuki Hirayasu; Yasuko Mori; Hisashi Arase
Journal:  J Biol Chem       Date:  2015-06-23       Impact factor: 5.157

3.  Structure-Function Dissection of Pseudorabies Virus Glycoprotein B Fusion Loops.

Authors:  Melina Vallbracht; Delphine Brun; Matteo Tassinari; Marie-Christine Vaney; Gérard Pehau-Arnaudet; Pablo Guardado-Calvo; Ahmed Haouz; Barbara G Klupp; Thomas C Mettenleiter; Felix A Rey; Marija Backovic
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

4.  Phosphorylation of varicella-zoster virus glycoprotein gpI by mammalian casein kinase II and casein kinase I.

Authors:  C Grose; W Jackson; J A Traugh
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

6.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

7.  Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells.

Authors:  G W Kemble; P Annunziato; O Lungu; R E Winter; T A Cha; S J Silverstein; R R Spaete
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus.

Authors:  Nancy J Jensen; Daniel P Depledge; Terry Fei Fan Ng; Jessica Leung; Mark Quinlivan; Kay W Radford; Jennifer Folster; Hung-Fu Tseng; Philip LaRussa; Steven J Jacobsen; Judith Breuer; D Scott Schmid
Journal:  Virology       Date:  2020-04-04       Impact factor: 3.513

9.  Different functional states of fusion protein gB revealed on human cytomegalovirus by cryo electron tomography with Volta phase plate.

Authors:  Zhu Si; Jiayan Zhang; Sakar Shivakoti; Ivo Atanasov; Chang-Lu Tao; Wong H Hui; Kang Zhou; Xuekui Yu; Weike Li; Ming Luo; Guo-Qiang Bi; Z Hong Zhou
Journal:  PLoS Pathog       Date:  2018-12-03       Impact factor: 6.823

10.  A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL.

Authors:  Yi Xing; Stefan L Oliver; TuongVi Nguyen; Claudio Ciferri; Avishek Nandi; Julie Hickman; Cinzia Giovani; Edward Yang; Giuseppe Palladino; Charles Grose; Yasushi Uematsu; Anders E Lilja; Ann M Arvin; Andrea Carfí
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.